Yes, we read the studies so you don’t have to. (Even the boring parts. Especially the boring parts.) These are the published studies behind our pigment and melasma information. Research findings describe 1064 nm and 532 nm picosecond technology in general, not one specific brand of device.
Warning: contains footnotes. May cause sounding very smart at brunch.
Feng J, Huang L. Comparison of Picosecond and Nanosecond Nd:YAG 1064-nm Lasers in the Treatment of Melasma: A Split-Face Randomized Clinical Trial. Plastic and Reconstructive Surgery, 2023. View source →
What it supports: In a small split-face trial (18 patients), 1064 nm picosecond technology improved melasma about as well as a Q-switched 1064 nm laser, with less pain and post-treatment redness and a lower potential risk of making melasma worse. Recurrence was 12.5% on both sides.
Feng J, Shen S, Song X, Xiang W. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Lasers in Medical Science, 2023. View source →
What it supports: Pooling six randomized trials, 1064 nm picosecond lasers were effective for melasma with no significant side effects. (The 755 nm wavelength was not better than topical creams, so we cite this paper for 1064 nm only.)
Wu W, Du Y, Zhang Y, Su Q, Wang F. Comparative appraisal with meta-analysis of picosecond versus nanosecond lasers for hyperpigmented disorders and tattoos. Lasers in Medical Science, 2025. View source →
What it supports: Across 20 randomized trials and one comparative study, picosecond lasers cleared skin pigment about as well as nanosecond lasers, caused less pain, and had a significantly lower rate of post-inflammatory hyperpigmentation. The safety advantage is best supported in Asian patients; data for other skin types are sparse.
Wu DC, Goldman MP, Wat H, Chan HHL. A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations. Lasers in Surgery and Medicine, 2021. View source →
What it supports: A review of 77 studies on picosecond lasers across tattoos, benign pigmented lesions, melasma, rejuvenation and scars, with evidence-based recommendations for each.
Gan C, Rodrigues M. An Update on New and Existing Treatments for the Management of Melasma. American Journal of Clinical Dermatology, 2024. View source →
What it supports: A review of melasma treatments: picosecond and Q-switched Nd:YAG lasers have similar effectiveness, with less pain and fewer acne-like breakouts with picosecond; recurrence stays high with all lasers; combination approaches are common.
Wu X, Wang X, Lin X, Shang Y, Cen Q, Zhang Z. Efficacy and safety of low-fluence 1064 nm picosecond laser with/without micro-lens arrays for melasma treatment: a randomized, split-face controlled study. Lasers in Medical Science, 2025. View source →
What it supports: In 30 patients, low-fluence 1064 nm picosecond treatment significantly reduced melasma severity, with no significant adverse events over six months of follow-up.
Khan QA, Abdi P, Farkouh C, et al. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: an updated systematic review and meta-analysis of randomized controlled trials. Lasers in Medical Science, 2023. View source →
What it supports: Combining laser treatment with topical tranexamic acid significantly improved melasma scores, supporting tranexamic acid as part of a laser plan.
Studies are about groups of people, and you’re one of a kind. That’s why your plan starts with a conversation, not a citation.